Small molecules with antiviral activity against the Ebola virus [v1; ref status: indexed, http://f1000r.es/523]
The recent outbreak of the Ebola virus in West Africa has highlighted the clear shortage of broad-spectrum antiviral drugs for emerging viruses. There are numerous FDA approved drugs and other small molecules described in the literature that could be further evaluated for their potential as antivira...
Main Authors: | Nadia Litterman, Christopher Lipinski, Sean Ekins |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2015-02-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/4-38/v1 |
Similar Items
-
Finding small molecules for the ‘next Ebola’ [v1; ref status: indexed, http://f1000r.es/542]
by: Sean Ekins, et al.
Published: (2015-02-01) -
Finding small molecules for the ‘next Ebola’ [v2; ref status: indexed, http://f1000r.es/5lb]
by: Sean Ekins, et al.
Published: (2015-07-01) -
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v1; ref status: indexed, http://f1000r.es/4qh]
by: Sean Ekins, et al.
Published: (2014-11-01) -
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v2; ref status: indexed, http://f1000r.es/4wt]
by: Sean Ekins, et al.
Published: (2014-12-01) -
Dynamics of Ebola epidemics in West Africa 2014 [v2; ref status: indexed, http://f1000r.es/5fh]
by: Robin J. Evans, et al.
Published: (2015-05-01)